Condition or Disorder Intervention vs. Control Outcome Follow-up Duration Event Rates % NNT (95% CI)
CER EER
Endoscopic re-treatment of bleeding peptic ulcer1 Endoscopy vs. surgery Mortality at 30 days, duration of hospitalization after treatment, ICU stay, need for blood transfusion and treatment-related complications 6 weeks 36 15 5 (3 to 25)
Remission rates in active Crohn disease2 Budesonide vs. mesalamine Remission 16 weeks 36 62 4 (3 to 10)
Endoscopic gastroduodenal ulcers in osteoarthritis3 Rofecoxib vs. Ibuprofen Endoscopic gastroduodenal ulcers ≥ 3 mm at 12 weeks 24 weeks 7 25 5 (4 to 9)
Women with irritable bowel syndrome4 Alosetron vs. placebo Relief of abdominal symptoms 1 month 29 41 8 (5 to 22)
Constipation 3 30 4 (3 to 5)
Bleeding peptic ulcer5 Omeprazole vs. placebo Recurrent bleeding 8 weeks 22.5 6.7 6 (4 to 14)
Hospital stay < 5 days 31.7 46.7 7 (4 to 38)
H pylori infection6 Clarithromycin. Iansoprazole, metronidazole vs clarithromycin, Iasoprazole, amoxicillin Eradication of H pylori 6 weeks 84 66 6 (3 to infinity)

References


  1. Gastroenterology. Oct 1999; 117: 776-83 
  2. N Engl J Med. 6 Aug 1998; 339: 370-4 
  3. N Engl J Med. 6 Aug 1998; 339: 370-4 
  4. Lancet. Mar 25, 2000; 355:1035-40 
  5. N Engl J Med. Aug 3, 2000; 343: 310-6 
  6. JAMA. 2003;290:1593-9